adinazolam mesylate
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The pharmacokinetics and pharmacodynamics of adinazolam mesylate (10 mg), N‐desmethyl adinazolam mesylate (NDMAD, 10 mg), and…
The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis…
AbstractPurpose. This work describes diffusivity measurements of drug (adinazolam mesylate) and water in a variety of solutions…
AbstractPurpose. A mathematical model is described for the prediction of the relative change in drug release rate as a function…
The pharmacokinetics and pharmacodynamics of adinazolam (AD) were evaluated in 21 elderly subjects (mean age, 69 ± 4 years) at…
A novel optical image analysis method was developed to examine the dynamic swelling behavior of hydroxypropyl methylcellulose…
In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly…
Adinazolam mesylate, a new triazolobenzodiazepine with antidepressant properties, was significantly superior to placebo based on…
ABSTRACT In a 6‐week, randomized, double‐blind study, adinazolam mezylate (Deracyn® Tablets, The Upjohn Company) was compared…